We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months

News   Sep 25, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months
 
 
 

RELATED ARTICLES

Brain Chip Makes for Precision Cancer Treatment

News

Researchers have developed a microfluidic brain chip which could be used for simultaneously assessing drug treatments for malignant brain tumors.

READ MORE

Targeting “DNA Rewiring” To Reduce Breast Cancer Relapse

News

Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.

READ MORE

Researchers Develop First Diagnostic Test for Novel Coronavirus in China

News

Researchers from the DZIF have developed a new laboratory assay to detect the novel Chinese coronavirus. The assay protocol has now been published by WHO as a guideline for diagnostic detection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE